Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

计划入组 69 人 · 首次发布于 2016 年 3 月 2 日

Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis

首次发布于 2012 年 4 月 10 日

Anatomical Shoulder™ Inverse/Reverse Study

计划入组 154 人 · 首次发布于 2015 年 6 月 9 日

CM-YJH01

Disperse Blue 106

C₁₄H₁₇N₅O₃S

ERR-alpha inverse agonists

Pulmatrix to Divest Phase 2-Ready Migraine Treatment and iSPERSE Technology Ahead of Cullgen Merger

Pulmatrix and Cullgen Mutually Waive No-Solicitation Clause While Awaiting Chinese Regulatory Approval for Merger

Gene Therapy and GPR6 Inverse Agonist Show Promise in Parkinson's Disease Trials